The corticotropin releasing factor system in cancer: expression and pathophysiological implications |
| |
Authors: | Athina Kaprara Kalliopi Pazaitou-Panayiotou Alexandros Kortsaris Ekaterini Chatzaki |
| |
Institution: | (1) Anticancer Hospital ‘Theagenio’, Thessaloniki, Greece;(2) Laboratory of Biochemistry, Democritus University of Thrace, Alexandroupolis, Thrace, Greece;(3) Department of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Dragana, 681 00 Alexandroupolis, Greece; |
| |
Abstract: | Malignant tumors express multiple factors that have some role in the regulating networks supporting their ectopic growth.
Recently, increased interest has been developing in the expression and biological role of the neuropeptides and receptors
of the corticotropin releasing factor (CRF) system, the principal neuroendocrine mediator of the stress response, especially
in the light of several R&D programs for small molecule antagonists that could present some anticancer therapeutic benefit.
In the present article, we review the literature suggesting that the CRF system could be involved in the regulation of human
cancer development. Potential implication in growth, metastasis, angiogenesis, or immune parameters via activation of locally
expressed receptors could be clinically exploited by presenting targets of new therapeutic approaches. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|